课题基金 / 基金详情

Protein phosphorylation of tumor suppressor gene p53 in leukemia cells and regulation of apoptosis-rated gene expression

Protein phosphorylation of tumor suppressor gene p53 in leukemia cells and regulation of apoptosis-rated gene expression
白血病细胞中抑癌基因p53的蛋白磷酸化及凋亡相关基因表达的调控
批准号:
10670944
负责人:
KOBAYASHI Tohru
金额:
$1.92万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
1998
资助国家:
日本
项目状态:
已结题
起止时间:
1998 至 1999

项目摘要

项目成果

KOBAYASHI Tohru的其他基金

相似基金

相关文献

中文摘要
翻译
(1)这两个辐射阿糖胞苷处理的BV 173人白血病细胞,其中含有野生型p53基因,导致细胞凋亡和诱导p53。p53下游基因Bax和Fas/APO-1在辐射中被激活,而在阿糖胞苷处理中仅Bax被激活。双向电泳结果显示,辐射和阿糖胞苷处理的BV 173细胞中p53蛋白具有不同的等电点,磷酸酶处理后p53蛋白的等电点趋于一致。P53-丝氨酸15、33和392在辐射、阿糖胞苷处理和阿霉素处理的BV 173细胞中磷酸化,没有差异。(2)K562红白血病细胞中Bax的瞬时过表达引起的凋亡细胞明显多于对照组。在转染Tet-On Bax诱导系统的野生型K562细胞中,Bax的过表达无任何细胞毒性信号,导致凋亡caspase-3激活,线粒体释放细胞色素c,线粒体膜电位改变。pancaspase抑制剂zVAD-favorite抑制线粒体上Bax过表达时的凋亡事件。这些研究结果表明,Bax蛋白,当存在高于阈值水平,是足以触发凋亡级联反应,其启动需要同时激活的半胱天冬酶不介导的线粒体细胞色素c释放在K562细胞。(3)在DLD-1结肠癌细胞中,Tet-On-Bu诱导的caspase活化和凋亡被认为是由线粒体细胞色素c释放介导的。Bax过表达也通过增加细胞色素c的释放而使KATOIII胃癌细胞对化疗药物诱导的凋亡敏感。综上所述,p53蛋白在不同的细胞毒性刺激下被不同的磷酸化,Bax诱导的caspase激活有两条途径:一条是由线粒体细胞色素c释放介导的,另一条不是由细胞色素c介导的。
英文摘要
(1) Both irradiated ara-C-treated BV173 human leukemia cells, which harbor the wild-type p53 gene, resulted in apoptosis and induction of p53. The downstream genes of p53, Bax and Fas/APO-1 were activated in irradiation, but only Bax in ara-C treatment. Two-dimensional gel electrophoresis revealed that the p53 proteins in irradiated and ara-C-treated BV173 cells had different isoelectric points which converged to a single isoelectric point after phosphatase treatment. P53-serine 15, 33, and 392 in irradiated, ara-C-treated and doxorubicin-treated BV173 cells were phosphorylated with no difference.(2) Transient Bax overexpression in K562 erythroleukemia cells caused significantly more apoptotic cells than the control. In wild type Bax-bearing K562 cells transfected with Tet-On Bax-inducible system, overexpression of Bax without any cytotoxic signal resulted in apoptosis caspase-3 activation, mitochondrial release of cytochrome c, and mitochondrial membrane potential change. A pancaspase inhibitor, zVAD-fmk, inhibited the apoptotic events in the presence of overexpression Bax on mitochondria. These findings suggest that Bax protein, when present above a threshold level, is sufficient to trigger apoptosis cascade, and its initiation requires simultaneous activation of caspases not mediated by mitochondrial cytochrome c release in K562 cells.(3) In DLD-1 colon cancer cells, Tet-On-Bax-induced caspase activation and apoptosis were considered to be mediated by mitochondrial cytochrome c release. Bax overexpression also sensitized KATOIII gastric cancer cells to chemotherapeutic agent-induced apoptosis through enhancing the cytochrome c release.Taken together, p53 proteins are differently phosphorylated by different cytotoxic stimuli, and Bax-induced caspase activation has two pathways ; one is mediated by mitochondrial cytochrome c release, and one not mediated by cytochrome c.
期刊论文(8)
专著(0)
科研奖励(0)
会议论文
Tohru Kobayashi: "Differential p53 phosphorylation and activation of apoptosis-promoting genes Bax and Fas/APO-1 by radiation and ara-C treatment"Cell Death & Differentiation. 5. 584-591 (1998)
Tohru Kobayashi:“通过辐射和 ara-C 处理,差异性 p53 磷酸化和凋亡促进基因 Bax 和 Fas/APO-1 的激活”细胞死亡
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Tohru Kobayashi, Sanbao Ruan, Katharina Clodi, Kay-Oliver Klische, Hiroshi Shiku, Michael Andreef, and Wei Zhang: "Overexpression of Bax gene sensitizes K562 erythroleukemia cells to apoptosis induced by selective chemotherapeutic agents"Oncogene. 16. 158
Tohru Kobayashi、Sanbao Ruan、Katharina Clodi、Kay-Oliver Klische、Hiroshi Shiku、Michael Andreef 和 Wei Zhang:“Bax 基因的过度表达使 K562 红白血病细胞对选择性化疗药物诱导的细胞凋亡敏感”癌基因。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Hidehiko Sawa, Tohru Kobayashi, Katsumi Mukai, Wei Zhang and Hiroshi Shiku: "Bax-overexpression enhances cytochrome c release from mitochondria and sensitizes KATOIII gastric cancer cells to chemotherapeutic agent-induced apoptosis"International Journal o
Hidehiko Sawa、Tohru Kobayashi、Katsumi Mukai、Wei Zhu 和 Hiroshi Shiku:“Bax 过表达增强线粒体中细胞色素 c 的释放,并使 KATOIII 胃癌细胞对化疗药物诱导的细胞凋亡敏感”国际期刊
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Tohru Kobayashi: "Overexpression of Bax gene sensitizes K562 erythroleukemia cells to apoptosis induced by selective chemotherapeutic agents." Oncogene. 16. 1587-1591 (1998)
Tohru Kobayashi:“Bax 基因的过度表达使 K562 红白血病细胞对选择性化疗药物诱导的细胞凋亡敏感。”
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
6
    Enantio-selective coordination using molecular template and novel application for intra-series separation of lanthanides
    • 批准号:
      22760655
    • 项目类别:
      Grant-in-Aid for Young Scientists (B)
    • 资助金额:
      $2.66万
    • 财政年份:
      2010
    • 负责人:
      KOBAYASHI Tohru
    • 依托单位:
    Molecular mechanisms of sexual plasticity during testicular differentiation and development in the medaka, Olyzias latipes
    • 批准号:
      21570065
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $3.08万
    • 财政年份:
      2009
    • 负责人:
      KOBAYASHI Tohru
    • 依托单位:
    Analysis of Toll-like receptor signal transduction in acute Kawasaki disease.
    • 批准号:
      20790757
    • 项目类别:
      Grant-in-Aid for Young Scientists (B)
    • 资助金额:
      $2.66万
    • 财政年份:
      2008
    • 负责人:
      KOBAYASHI Tohru
    • 依托单位:
    Molecular mechanisms of germ cell differntiation before and during meiosis
    国内基金
    海外基金
    针刺强度通过调控Beclin-1/LC3与Bcl-2/Bax平衡促进面神经修复的量效机制研究
    • 批准号:
      2026JJ82043
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
      张珂胜
    • 依托单位:
    促凋亡蛋白(BAX和BAK)调控非洲猪瘟病毒复制的分子机制
    • 批准号:
      2026JJ60376
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
      向智勇
    • 依托单位:
    生物钟基因BMAL1激活SirT3/Ku70/Bax通路调控线粒体功能在脓毒症心肌功能障碍中的作用
    • 批准号:
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2025
    • 负责人:
      冷莹雪
    • 依托单位:
    BAX/BAK1依赖的线粒体外膜透化激活 mtDNA/cGAS-STING轴诱导 β 细胞线粒体 凋亡及降糖调脂方干预机制研究
    • 批准号:
    • 项目类别:
      省市级项目
    • 资助金额:
      10.0万元
    • 批准年份:
      2025
    • 负责人:
      罗金丽
    • 依托单位: